{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:34:54Z","timestamp":1790973294500,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T00:00:00Z","timestamp":1594252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T00:00:00Z","timestamp":1594252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the infectious agent responsible for coronavirus disease 2019 (COVID-19). Respiratory and gastrointestinal manifestations of SARS-CoV-2 are well described, less defined is the clinical neurological spectrum of COVID-19. We reported a case of COVID-19 patient with acute monophasic Guillain-Barr\u00e9 syndrome (GBS), and a literature review on the SARS-CoV-2 and GBS etiological correlation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case Description<\/jats:title>\n                <jats:p>A 68 years-old man presented to the emergency department with symptoms of acute progressive symmetric ascending flaccid tetraparesis. Oropharyngeal swab for SARS-CoV-2 tested positive. Neurological examination showed bifacial nerve palsy and distal muscular weakness of lower limbs. The cerebrospinal fluid assessment showed an albuminocytologic dissociation. Electrophysiological studies showed delayed distal latencies and absent F waves in early course. A diagnosis of Acute Inflammatory Demyelinating Polyradiculoneuropathy (AIDP) subtype of GBS was then made.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Neurological manifestations of COVID-19 are still under study. The case we described of GBS in COVID-19 patient adds to those already reported in the literature, in support of SARS-CoV-2 triggers GBS. COVID-19 associated neurological clinic should probably be seen not as a corollary of classic respiratory and gastrointestinal symptoms, but as SARS-CoV-2-related standalone clinical entities. To date, it is essential for all Specialists, clinicians and surgeons, to direct attention towards the study of this virus, to better clarify the spectrum of its neurological manifestations.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10072-020-04553-9","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T00:03:27Z","timestamp":1594253007000},"page":"607-612","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Is Guillain-Barr\u00e8 syndrome triggered by SARS-CoV-2? Case report and literature review"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6463-5000","authenticated-orcid":false,"given":"Edoardo","family":"Agosti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Giorgianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"D\u2019Amore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Vinacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Balbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,9]]},"reference":[{"key":"4553_CR1","unstructured":"WHO Director-General\u2019s opening remarks at the media briefing on COVID-19 - 11 March 2020. https:\/\/www.who.int\/dg\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-11-march-2020"},{"key":"4553_CR2","unstructured":"Track reported cases of COVID-19"},{"key":"4553_CR3","doi-asserted-by":"publisher","first-page":"m1470","DOI":"10.1136\/bmj.m1470","volume":"369","author":"P Vetter","year":"2020","unstructured":"Vetter P, Lan Vu D, L\u2019Huillier AG, Schibler M, Kaiser L, Jacquerioz F (2020) Clinical features of covid-19. BMJ. 369:m1470. https:\/\/doi.org\/10.1136\/bmj.m1470","journal-title":"BMJ."},{"key":"4553_CR4","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s12028-020-00978-4","volume":"32","author":"EJ Needham","year":"2020","unstructured":"Needham EJ, Chou SH-Y, Coles AJ, Menon DK (2020) Neurological implications of COVID-19 infections. Neurocrit Care 32:667\u2013671. https:\/\/doi.org\/10.1007\/s12028-020-00978-4","journal-title":"Neurocrit Care"},{"key":"4553_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jocn.2020.05.017","volume":"77","author":"I Ahmad","year":"2020","unstructured":"Ahmad I, Rathore FA (2020) Neurological manifestations and complications of COVID-19: a literature review. J Clin Neurosci 77:8\u201312. https:\/\/doi.org\/10.1016\/j.jocn.2020.05.017","journal-title":"J Clin Neurosci"},{"key":"4553_CR6","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1007\/s10072-006-0548-4","volume":"27","author":"V Cosi","year":"2006","unstructured":"Cosi V, Versino M (2006) Guillain-Barr\u00e9 syndrome. Neurol Sci 27:S47\u2013S51. https:\/\/doi.org\/10.1007\/s10072-006-0548-4","journal-title":"Neurol Sci"},{"issue":"11","key":"4553_CR7","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1007\/s10072-019-03926-z","volume":"40","author":"R De Andrade da Silva","year":"2019","unstructured":"De Andrade da Silva R, Carvalho Cremaschi R, Rebello Pinho JR, Bosco de Oliveira J, Morgadinho Coelho F (2019) Guillain\u2013Barr\u00e9 syndrome\u2014the challenge of unrecognized triggers. Neurol Sci 40(11):2403\u20132404. https:\/\/doi.org\/10.1007\/s10072-019-03926-z","journal-title":"Neurol Sci"},{"issue":"4","key":"4553_CR8","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s100720070081","volume":"21","author":"Guillain-Barr\u00e9 Syndrome Study Group","year":"2000","unstructured":"Guillain-Barr\u00e9 Syndrome Study Group (2000) Guillain-Barr\u00e9 syndrome: an Italian multicentre case-control study. Neurol Sci 21(4):229\u2013234. https:\/\/doi.org\/10.1007\/s100720070081","journal-title":"Neurol Sci"},{"key":"4553_CR9","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(08)70215-1","volume":"7","author":"PA Van Doorn","year":"2008","unstructured":"Van Doorn PA, Ruts L, Jacobs BC (2008) Clinical features, pathogenesis, and treatment of Guillain-Barr\u00e8 syndrome. Lancet Neurol 7:939\u2013950. https:\/\/doi.org\/10.1016\/S1474-4422(08)70215-1","journal-title":"Lancet Neurol"},{"key":"4553_CR10","doi-asserted-by":"publisher","unstructured":"Ottaviani D, Boso F, Tranquillini E, Gapeni I, Pedrotti G, Cozzio S, Guarrera GM, Giometto B (2020) Early Guillain-Barr\u00e9 syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital. Neurol Sci. https:\/\/doi.org\/10.1007\/s10072-020-04449-8","DOI":"10.1007\/s10072-020-04449-8"},{"key":"4553_CR11","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S1474-4422(20)30109-5","volume":"19","author":"H Zhao","year":"2020","unstructured":"Zhao H, Shen D, Zhou H, Liu J, Chen S (2020) Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol 19:383\u2013384. https:\/\/doi.org\/10.1016\/S1474-4422(20)30109-5","journal-title":"Lancet Neurol"},{"key":"4553_CR12","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jocn.2020.04.062","volume":"76","author":"Z Sedaghata","year":"2020","unstructured":"Sedaghata Z, Karimib N (2020) Guillain Barre syndrome associated with COVID-19 infection: a case report. J Clin Neurosci 76:233\u2013235. https:\/\/doi.org\/10.1016\/j.jocn.2020.04.062","journal-title":"J Clin Neurosci"},{"key":"4553_CR13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1212\/NXI.0000000000000741","volume":"29","author":"P Alberti","year":"2020","unstructured":"Alberti P, Beretta S, Piatti M, Karantzoulis A, Piatti ML, Santoro P, Vigan\u00f2 M, Giovannelli G, Pirro F, Montisano DA, Appollonio I, Ferrarese C (2020) Guillain-Barr\u00e9 syndrome related to COVID-19 infection. Neurol Neuroimmunol Neuroinflamm 29:7. https:\/\/doi.org\/10.1212\/NXI.0000000000000741","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"4553_CR14","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1007\/s00415-020-09849-6","volume":"267","author":"M Padroni","year":"2020","unstructured":"Padroni M, Mastrangelo V, Asioli GM, Pavolucci L, Abu-Rumeileh S, Piscaglia MG, Querzani P, Callegarini C, Foschi M (2020) Guillain-Barr\u00e8 syndrome following COVID-19: new infection, old complication? J Neurol 267:1877\u20131879. https:\/\/doi.org\/10.1007\/s00415-020-09849-6","journal-title":"J Neurol"},{"key":"4553_CR15","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.neurol.2020.04.007","volume":"176","author":"H El Otmani","year":"2020","unstructured":"El Otmani H, El Moutawakil B, Rafai M-A, El Benna N, El Kettani C, Soussi M, El Mdaghri N, Barrou H, Afif H (2020) Covid-19 and Guillain-Barr\u00e9 syndrome: more than a coincidence! Rev Neurol (Paris) 176:518\u2013519. https:\/\/doi.org\/10.1016\/j.neurol.2020.04.007","journal-title":"Rev Neurol (Paris)"},{"key":"4553_CR16","doi-asserted-by":"publisher","first-page":"30698","DOI":"10.1016\/j.bbi.2020.04.074","volume":"S0889-1591","author":"M Coen","year":"2020","unstructured":"Coen M, Jeanson G, Culebras Almeida LA, H\u00fcbers A, Stierlin F, Najjar I, Ongaro M, Moulin K, Makrygianni M, Leemann B, Kronig I, Bertrand J, Reny JL, Schibler M, Serratrice J (2020) Guillain-Barr\u00e9 syndrome as a complication of SARS-CoV-2 infection. Brain Behav Immun S0889-1591:30698\u20133069X. https:\/\/doi.org\/10.1016\/j.bbi.2020.04.074","journal-title":"Brain Behav Immun"},{"key":"4553_CR17","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1056\/NEJMc2009191","volume":"382","author":"G Toscano","year":"2020","unstructured":"Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P, Cuzzoni MG, Franciotta D, Baldanti F, Daturi R, Postorino P, Cavallini A, Micieli G (2020) Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2. N Engl J Med 382:2574\u20132576. https:\/\/doi.org\/10.1056\/NEJMc2009191","journal-title":"N Engl J Med"},{"key":"4553_CR18","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/jns.12382","volume":"25","author":"E Scheidl","year":"2020","unstructured":"Scheidl E, Diez Canseco D, Hadji-Naumov A, Bereznai (2020) Guillain-Barre syndrome during SARS-CoV-2 pandemic: a case report and review of recent literature. JPNS. 25:204\u2013207. https:\/\/doi.org\/10.1111\/jns.12382","journal-title":"JPNS."},{"key":"4553_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00415-020-09907-z","volume":"26","author":"N Riva","year":"2020","unstructured":"Riva N, Russo T, Falzone YM, Strollo M, Amadio S, Del Carro U, Locatelli M, Filippi M, Fazio R (2020) Post-infectious Guillain\u2013Barr\u00e9 syndrome related to SARS-CoV-2 infection: a case report. J Neurol 26:1\u20133. https:\/\/doi.org\/10.1007\/s00415-020-09907-z","journal-title":"J Neurol"},{"key":"4553_CR20","doi-asserted-by":"publisher","unstructured":"Assini A, Benedetti L, Di Maio S, Schirinzi E, Del Sette M (2020) New clinical manifestation of COVID-19 related Guillain-Barr\u00e8 syndrome highly responsive to intravenous immunoglobulins: two Italian cases. Neurol Sci. https:\/\/doi.org\/10.1007\/s10072-020-04484-5","DOI":"10.1007\/s10072-020-04484-5"},{"key":"4553_CR21","doi-asserted-by":"publisher","unstructured":"Bigaut K, Mallaret M, Baloglu S, Nemoz B, Morand P, Baicry F, Godon A, Voulleminot P, Kremer L, Chanson J-B, De Seze J (2020) Guillain-Barr\u00e8 syndrome related to SARS-CoV-2 infection. https:\/\/doi.org\/10.1212\/NXI.0000000000000785","DOI":"10.1212\/NXI.0000000000000785"},{"key":"4553_CR22","doi-asserted-by":"publisher","unstructured":"Romero-S\u00e1nchez CM, D\u00edaz-Maroto I, Fern\u00e1ndez-D\u00edaz E, S\u00e1nchez-Larsen A, Layos-Romero A, Garc\u00eda-Garc\u00eda J, Gonz\u00e1lez E, Redondo-Pe\u00f1as I, Perona-Moratalla AB, Del Valle-P\u00e9rez JA, Gracia-Gil J, Rojas-Bartolom\u00e9 L, Feria-Vilar I, Monteagudo M, Palao M, Palaz\u00f3n-Garc\u00eda E, Alcahut-Rodr\u00edguez C, Sopelana-Garay D, Moreno Y, Ahmad J, Segura T (2020) Neurologic manifestations in hospitalized patients with COVID-19: the ALBACOVID registry. Neurology:10.1212\/WNL.0000000000009937. https:\/\/doi.org\/10.1212\/WNL.0000000000009937","DOI":"10.1212\/WNL.0000000000009937"},{"key":"4553_CR23","doi-asserted-by":"publisher","unstructured":"Chan JC, Ebadi H, Sarna JR (2020) Guillain-Barr\u00e9 syndrome with facial diplegia related to SARS-CoV-2 infection. Can J Neurol Sci:1\u20133. https:\/\/doi.org\/10.1017\/cjn.2020.106","DOI":"10.1017\/cjn.2020.106"},{"key":"4553_CR24","doi-asserted-by":"publisher","unstructured":"Baig AM, Khaleeq A, Ali U, Syeda H (2020) Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci:995\u2013998. https:\/\/doi.org\/10.1021\/acschemneuro.0c00122","DOI":"10.1021\/acschemneuro.0c00122"},{"issue":"11","key":"4553_CR25","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1007\/s10072-016-2644-4","volume":"37","author":"J Fukae","year":"2016","unstructured":"Fukae J, Tsugawa J, Ouma S, Umezu T, Kusunoki S, Tsuboi Y (2016) Guillain-Barr\u00e8 and Miller Fisher syndromes in patients with anti-hepatitis E virus antibody: a hospital-based survey in Japan. Neurol Sci 37(11):1849\u20131851. https:\/\/doi.org\/10.1007\/s10072-016-2644-4","journal-title":"Neurol Sci"},{"issue":"12","key":"4553_CR26","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1007\/s10072-014-1841-2","volume":"35","author":"A Filia","year":"2014","unstructured":"Filia A, Lauria G (2014) Guillain-Barr\u00e8 syndrome following measles infection: case report and review of the literature. Neurol Sci 35(12):2017\u20132018. https:\/\/doi.org\/10.1007\/s10072-014-1841-2","journal-title":"Neurol Sci"},{"key":"4553_CR27","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","volume":"387","author":"VM Cao-Lormeau","year":"2016","unstructured":"Cao-Lormeau VM, Blake A, Mons S, Last\u00e8re S, Roche C, Vanhomwegen J, Ghawch\u00e9 F (2016) Guillain-Barr\u00e9 syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet. 387:1531\u20131539. https:\/\/doi.org\/10.1016\/S0140-6736(16)00562-6","journal-title":"Lancet."},{"key":"4553_CR28","doi-asserted-by":"publisher","first-page":"e00771","DOI":"10.1016\/j.idcr.2020.e00771","volume":"20","author":"A Virani","year":"2020","unstructured":"Virani A, Rabold E, Hanson T, Haag A, Elrufay R, Cheema T, Balaan M, Bhanotc N (2020) Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection. IDCases. 20:e00771. https:\/\/doi.org\/10.1016\/j.idcr.2020.e00771","journal-title":"IDCases."},{"key":"4553_CR29","doi-asserted-by":"publisher","first-page":"30522","DOI":"10.1016\/j.neurol.2020.04.003","volume":"S0035-3787","author":"JP Camdessanche","year":"2020","unstructured":"Camdessanche JP, Morel J, Pozzetto B, Paul S, Tholance Y, Botelho-Nevers E (2020) COVID-19 may induce Guillain-Barr\u00e9 syndrome. Rev Neurol (Paris) S0035-3787:30522\u201330521. https:\/\/doi.org\/10.1016\/j.neurol.2020.04.003","journal-title":"Rev Neurol (Paris)"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04553-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-020-04553-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04553-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T23:54:26Z","timestamp":1625788466000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-020-04553-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,9]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["4553"],"URL":"https:\/\/doi.org\/10.1007\/s10072-020-04553-9","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,9]]},"assertion":[{"value":"30 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board approval"}},{"value":"Consent for publication was obtained for every individual person\u2019s data included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}